Acorda Therapeutics
ACOR
#10565
Rank
S$1.06 M
Marketcap
S$0.86
Share price
0.00%
Change (1 day)
-95.78%
Change (1 year)

Earnings for Acorda Therapeutics (ACOR)

Earnings in 2024 (TTM): -S$0.36 Billion

According to Acorda Therapeutics 's latest financial reports the company's current earnings are S$0.11 Billion. In 2023 the company made an earning of -S$0.35 Billion a decrease over its 2022 earnings that were of -S$6.92 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Acorda Therapeutics from 2006 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -S$0.36 Billion5.07%
2023 -S$0.35 Billion4848.63%
2022 -S$6.92 Million-93.25%
2021 -S$0.11 Billion2.52%
2020 -S$99.91 Million-69.45%
2019 -S$0.33 Billion-700.62%
2018 S$54.45 M-118.02%
2017 -S$0.31 Billion805.99%
2016 -S$33.36 Million-173.88%
2015 S$45.15 M-6.58%
2014 S$48.33 M20.19%
2013 S$40.21 M18.7%
2012 S$33.87 M-26.54%
2011 S$46.11 M
2009 -S$0.11 Billion10.65%
2008 -S$95.18 Million86.17%
2007 -S$51.12 Million68.1%
2006 -S$30.42 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Repligen
RGEN
S$33.87 M-109.62%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
S$0.88 B-349.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Affimed
AFMD
-S$99.11 Million-71.86%๐Ÿ‡ฉ๐Ÿ‡ช Germany
Sarepta Therapeutics
SRPT
-S$0.33 Billion-7.21%๐Ÿ‡บ๐Ÿ‡ธ USA